Naoto Saito
Overview
Explore the profile of Naoto Saito including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
1318
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Izumiya M, Nobuoka H, Endo H, Ueno R, Mimura M, Saito N, et al.
Biomedicines
. 2025 Feb;
13(2).
PMID: 40002902
: The translation of in vitro biomaterial evaluations into successful clinical applications often fails due to discrepancies with in vivo results. Previously, we demonstrated that differences in culture medium conditions...
2.
Makiyama F, Kawase S, Omi A, Tanikawa Y, Kotani T, Shirayama T, et al.
Sci Rep
. 2025 Jan;
15(1):466.
PMID: 39747517
Lysophosphatidylethanolamine (LPE) is a bioactive lipid mediator involved in diverse cellular functions. In this study, we investigated the effects of three LPE species, 1-palmitoyl LPE (16:0 LPE), 1-stearoyl LPE (18:0...
3.
Nakamura M, Yamamoto Y, Zhang M, Ueda K, Aoki K, Saito N, et al.
Nanoscale
. 2024 Aug;
16(35):16632-16640.
PMID: 39171423
Previously, we showed that the anti-osteoclast effect of zoledronate (ZOL), a type of bisphosphonate, is enhanced when it is used as a nanocomposite comprising ZOL, an "oxidized single-walled carbon nanohorn...
4.
Hatanaka T, Saito N, Kakizaki S, Hiraoka A, Tada T, Kariyama K, et al.
Oncology
. 2024 Aug;
103(2):94-106.
PMID: 39163847
Introduction: Gastrointestinal varices rupture is considered to be prone to occur during atezolizumab and bevacizumab (Atez/Bev) treatment. This study aimed to investigate predictive factors affecting the increase in spleen volume...
5.
Koyama S, Tensho K, Takashimizu I, Aoki T, Shimodaira H, Iwaasa T, et al.
J Wound Care
. 2024 Mar;
33(Sup3a):lxi-lxviii.
PMID: 38457269
Objective: The use of 2-octyl cyanoacrylate with polyester mesh (OCA-M) has become common in total hip and knee arthroplasty (THA, TKA). We aimed to compare the safety and cosmetic outcomes...
6.
Aoki K, Ideta H, Komatsu Y, Tanaka A, Kito M, Okamoto M, et al.
Bioengineering (Basel)
. 2024 Feb;
11(2).
PMID: 38391666
Calcium phosphate-based synthetic bone is broadly used for the clinical treatment of bone defects caused by trauma and bone tumors. Synthetic bone is easy to use; however, its effects depend...
7.
Ma C, Izumiya M, Nobuoka H, Ueno R, Mimura M, Ueda K, et al.
Nanomaterials (Basel)
. 2024 Feb;
14(3).
PMID: 38334522
The progress in artificial bone research is crucial for addressing fractures and bone defects in the aging population. However, challenges persist in terms of biocompatibility and structural complexity. Nanotechnology provides...
8.
Hatanaka T, Yata Y, Saito N, Nakano S, Nakano Y, Hazama Y, et al.
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831630
This study aimed to investigate the effect of being overweight on the outcome of ablation therapy for patients with early-stage hepatocellular carcinoma (HCC). This retrospective study included 198 patients with...
9.
Ueda K, Ma C, Izumiya M, Kuroda C, Ishida H, Uemura T, et al.
Nanomaterials (Basel)
. 2023 Jan;
13(2).
PMID: 36677997
With the advent of nanotechnology, the use of nanoparticles as drug delivery system (DDS) has attracted great interest. We aimed to apply carbon nanohorns (CNHs) as DDS in the development...
10.
Hatanaka T, Naganuma A, Furusawa A, Tamura Y, Saito N, Suzuki Y, et al.
Oncology
. 2023 Jan;
101(3):193-202.
PMID: 36649691
Introduction: We previously reported 2 cases of esophageal varices rupture during atezolizumab and bevacizumab (Atez/Bev) treatment, in which the spleen volume gradually increased. The aim of this retrospective study is...